ResearchMoz

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014

GlobalData
Published Date » 2014-06-20
No. Of Pages » 159
   
 Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014 provides data on the Bipolar Disorder (Manic Depression) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bipolar Disorder (Manic Depression). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bipolar Disorder (Manic Depression). This report is built using data and information sourced from proprietary databases, primary and secondary research and...
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bipolar Disorder (Manic Depression) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bipolar Disorder (Manic Depression) 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Bipolar Disorder (Manic Depression) 38
Mar 31, 2014: Forest Laboratories and Gedeon Richter Announce Positive Phase IIb Topline Results for Cariprazine for the Treatment of Bipolar Depression 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Eli Lilly and Company 44
Clinical Trial Overview of Eli Lilly and Company 44
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Johnson & Johnson 50
Clinical Trial Overview of Johnson & Johnson 50
Otsuka Holdings Co., Ltd. 53
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 53
GlaxoSmithKline plc 56
Clinical Trial Overview of GlaxoSmithKline plc 56
Abbott Laboratories 58
Clinical Trial Overview of Abbott Laboratories 58
Merck & Co., Inc. 60
Clinical Trial Overview of Merck & Co., Inc. 60
Bristol-Myers Squibb Company 62
Clinical Trial Overview of Bristol-Myers Squibb Company 62
Novartis AG 64
Clinical Trial Overview of Novartis AG 64
Clinical Trial Overview of Top Institutes / Government 66
National Institute of Mental Health 66
Clinical Trial Overview of National Institute of Mental Health 66
Massachusetts General Hospital 69
Clinical Trial Overview of Massachusetts General Hospital 69
University of Pittsburgh 72
Clinical Trial Overview of University of Pittsburgh 72
U.S. Department of Veterans Affairs 73
Clinical Trial Overview of U.S. Department of Veterans Affairs 73
Mclean Hospital 74
Clinical Trial Overview of Mclean Hospital 74
University of Texas Southwestern Medical Center at Dallas 75
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 75
University of Cincinnati 76
Clinical Trial Overview of University of Cincinnati 76
University of British Columbia 77
Clinical Trial Overview of University of British Columbia 77
University Hospitals of Cleveland 78
Clinical Trial Overview of University Hospitals of Cleveland 78
Lindner Center of HOPE 79
Clinical Trial Overview of Lindner Center of HOPE 79
Five Key Clinical Profiles 80

Appendix 157
Abbreviations 157
Definitions 157
Research Methodology 158
Secondary Research 158
About GlobalData 159
Contact Us 159
Disclaimer 159
Source 159

List of Tables


Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bipolar Disorder (Manic Depression) Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Bipolar Disorder (Manic Depression) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Bipolar Disorder (Manic Depression) Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 33
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 39
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 44
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 47
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 50
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 53
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 56
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 58
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 60
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 62
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 64
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 66
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 69
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 72
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 73
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2014* 74
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2014* 75
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014* 76
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 77
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Cleveland, 2014* 78
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Lindner Center of HOPE, 2014* 79

List of Figures


Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 33
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 35
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
GlobalData Methodology 158

Upcoming Reports:

Dual Chamber Injectors And Syringes Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Dual chamber injectors and syringes aremedical devices used to store active pharmaceutical components or biological substances (such as tissue, blood or serum) that are not stable for extended period of time. These devices helps to maintain sterility of drugs before the time of injection in order to avoid drug loss.For example, liquid proteins drugs require refrigeration before dispensing thus, dual chamber injectors and syringes helps to manage proper storage condition of these drugs. Thus, proper storage of these drugs reduces the adverse effects of drug delivery. Advancement in...
Remote Patient Monitoring Devices Market - Global Industry Size, Share, Analysis, Upcoming Technologies, Current Trends And Forecasts 2012 - 2018
By - Transparency Market Research
Global remote patient monitoring (RPM) devices market is forecasted to reach $556.9 million by the year 2016 at the compounded annual growth rate of 10% during the forecasted period. Some of the major factors responsible for this growth are continuously increasing number of patients suffering from chronic disorders like cardiovascular illnesses and diabetes and increasing number of elderly population, as these people often prefer house monitoring as it avoids travelling and waiting time. Cardiac remote patient monitoring is the largest segment of this industry and it is expected to...
Wearable Electronics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Wearable electronics are accessories with advanced electronic technologies. Wearable devices are worn on the body, which enable wireless networking and mobile computing. These devices enable end-users to integrate computer in their daily activity and use technology to take advantage of advanced features and characteristics. Wearable electronics devices include product such as smart goggles, finger  worn scanners, wrist wears such as wrist bands and electronics watches, foot wears namely fitness and sport shoes and athletic shoes, and others products such as neck-wear and head bands....

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Ford Recalls 65,000 Fusion Models Due to Issues in Ignition Key
Nov 20, 2014  
If anything defines the world of automobiles currently, it would be recalls. It seems that a flood of automobiles has surrounded the global automobiles industry, which once represented a flourishing and highly profitable industry.  The current automobile giants ordering yet another recall is Ford Motors Co. Ford declared on Tuesday that it is recalling nearly 65,000 sedans from...
3D Printed Heart Model for Better Cardiological Treatment
Nov 20, 2014  
According to research carried out by the American Heart Association’s Scientific Sessions 2014, surgeons will be able to treat complex heart disorders in patients, with the help of a three dimensional experimental printed model of the heart. For surgical planning, most cardiac surgeons make use of two dimensional images of the heart taken by MRI, ultrasound, and X-ray. But the problem is...
Los Angeles Auto Show Kicks Off
Nov 20, 2014  
The Los Angeles Auto Show kicked off on Wednesday with a rather upbeat mood. Motoring machines, industry metrics, and hybrid models – the show has lived up to its reputation once more. The Los Angeles Auto Show has begun touring North America from the Los Angeles Convention Center, and the commencement has already had an impact on the market. Gasoline prices dropped under US$3...
Scottish Government to Inject 200 Million Pounds in the Housing Sector
Nov 19, 2014  
The construction and the housing industries of Scotland will get a major financial boost from the Scottish government in terms of additional funding worth 200 million pounds. The main rationale of such a financial boost is to stimulate the housing sector and also safeguarding employment in the construction industry. The housing minister of Scotland has requested the housing leaders to work...
Quarterly Dividend of $0.10 Declared by Tyson Foods, Inc.
Nov 19, 2014  
A quarterly dividend on November 18th was declared by Tyson Foods, reported Analyst Ratings Network.com. The shareholders of the February 27th record will be awarded a dividend of 0.10 per share on March 13th.  This represents a yield of 0.94% and a $0.40 dividend on an annualized basis. However, the ex-dividend date of this particular dividend is February 25th.  Such...